News
BEAT
0.6863
-3.35%
-0.0238
HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection
TipRanks · 14h ago
HeartBeam Grants Founder Performance-Based Equity and Bonus Incentives
TipRanks · 1d ago
HeartBeam grants President Branislav Vajdic 2,800,000 performance-based RSUs
PUBT · 1d ago
Weekly Report: what happened at BEAT last week (0615-0619)?
Weekly Report · 1d ago
Weekly Report: what happened at BEAT last week (0608-0612)?
Weekly Report · 06/15 10:12
Weekly Report: what happened at BEAT last week (0601-0605)?
Weekly Report · 06/08 10:09
HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
TipRanks · 06/02 18:30
HeartBeam Publishes JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain Patients
Benzinga · 06/02 11:20
HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG
TipRanks · 06/02 11:05
HeartBeam study in JACC Advances shows at-home ECG algorithm identifies heart attack risk in chest pain patients
PUBT · 06/02 11:01
HeartBeam posts investor deck on at-home, cable-free synthesized 12-lead ECG platform for arrhythmia assessment
PUBT · 06/01 23:51
Weekly Report: what happened at BEAT last week (0525-0529)?
Weekly Report · 06/01 10:12
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
TipRanks · 05/26 17:00
Weekly Report: what happened at BEAT last week (0518-0522)?
Weekly Report · 05/25 10:15
Heartbeam Price Target Cut to $2.50/Share From $5.50 by HC Wainwright & Co.
Dow Jones · 05/22 11:11
Heartbeam Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/22 11:11
HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5
Benzinga · 05/22 11:01
HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright
TipRanks · 05/22 10:10
HEARTBEAM, INC. <BEAT.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $2.5 FROM $5.5
Reuters · 05/22 10:10
U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday
Reuters · 05/22 06:49
More
Webull provides a variety of real-time BEAT stock news. You can receive the latest news about Heartbeam Inc through multiple platforms. This information may help you make smarter investment decisions.
About BEAT
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.